Perform Another (Advanced) Search

1.  CenterWatch: New Medical Therapies in Disease Category (459), Blood Transfusions
...CenterWatch: New Medical Therapies in Disease Category (459), Blood Transfusions Blood Transfusions Patient Medical Areas • Hematology • Trauma/Emergency Medicine November 7, 2005 Sangart issued positive ...
View Page

2.  CenterWatch: Clinical Trials in Category (459) Blood Transfusions
...CenterWatch: Clinical Trials in Category (459) Blood Transfusions Blood Transfusions State • California California Duarte : City of Hope New! Longitudinal Molecular Profiling of Islet ...
View Page

3.  Study Posting (1819) Trial #83926, Sickle Cell Disease, Cincinnati, OH
...who have sickle cell anemia and who can join a study to find out if blood transfusions can prevent new brain injuries known as strokes or silent infarcts. Both are brain injuries ...
View Page

4.  Study Posting (2246) Trial #117762, Blood Transfusions, Duarte, CA
...Study Posting (2246) Trial #117762, Blood Transfusions, Duarte, CA Trial Information Monitoring Islet Graft Integrity with Bidirectional Pyrophosphorolysis- Activated Polymerization Allele-Specific ...
View Page

5.  Study Posting (2246) Trial #117773, Blood Transfusions, Duarte, CA
...Study Posting (2246) Trial #117773, Blood Transfusions, Duarte, CA Trial Information Longitudinal Molecular Profiling of Islet Recipient's Blood You have been ...
View Page

6.  Study Posting (2246) Trial #88834, Blood Transfusions, Duarte, CA
...Study Posting (2246) Trial #88834, Blood Transfusions, Duarte, CA Trial Information Standardized Nursing Intervention Protocol for HCT Patients You have been asked ...
View Page

7.  CenterWatch New Medical Therapies™ in Trauma/Emergency Medicine
...CenterWatch New Medical Therapies™ in Trauma/Emergency Medicine Trauma/Emergency Medicine Abdominal Surgery Blood Transfusions Burns and Burn Infections COPD (Chronic Obstructive Pulmonary Disease) Hemorrhages Post-Surgical Pain Sepsis and ...
View Page

8.  CenterWatch: Clincial Trial Listings in Trauma/Emergency Medicine
...CenterWatch: Clincial Trial Listings in Trauma/Emergency Medicine Clinical Trials in Trauma/Emergency Medicine Blood Transfusions   (2, 2 New! ) COPD (Chronic Obstructive Pulmonary Disease)   (140, 5 New! ) Hemorrhages   (1) Surgery   (13 ...
View Page

9.  CenterWatch New Medical Therapies™ in Hematology
...CenterWatch New Medical Therapies™ in Hematology Hematology Acute Myelogenous Leukemia (AML) Anemia Blood Clots Blood Transfusions Bone Marrow Transplant Candidemia/Candidiasis Chronic Renal Anemia Gaucher Disease Hematologic Cancer Hemoglobinuria, Paroxysmal Hemophilia ...
View Page

10.  CenterWatch: Clincial Trial Listings in Hematology
...23, 2 New! ) Anemia   (2525) Aneurysm   (7, 5 New! ) Aplastic Anemia   (1) Blood Clots   (1) Blood Transfusions   (2, 2 New! ) Bone Marrow Transplant   (19, 3 New! ) Candidemia/Candidiasis   (1) Hematologic Cancer   (22 ...
View Page

11. Clinical Trial Results by Drug Names
...at a starting dose of 150 IU/kg s.c. tiw, or standard treatment (supported blood transfusion and iron supplements, as necessary), coinciding with the start of platinum-based chemotherapy. The number ...
View Page

12. Clinical Trial Results by Drug Names
...at a starting dose of 150 IU/kg s.c. tiw, or standard treatment (supported blood transfusion and iron supplements, as necessary). The number and volume of blood transfusions were documented during ...
View Page

13. Clinical Trial Results by Drug Names
...16 weeks, increasing to 450 IU/kg twice weekly if, after 4 weeks of treatment, blood transfusion was necessary in the last week or the hemoglobin (Hb) level did not increase by ...
View Page

14.  Study Posting (4519) Trial #104424, Anemia, Xi'An, China
...leukemia who are receiving anti-tumor chemotherapy. Patients will receive either NeoRecormon or standard therapy (blood transfusion and iron supplement) The anticipated time on study treatment is 3-12 months, and the ...
View Page

15.  Study Posting (4519) Trial #101899, Anemia, Wuhan, China
...leukemia who are receiving anti-tumor chemotherapy. Patients will receive either NeoRecormon or standard therapy (blood transfusion and iron supplement) The anticipated time on study treatment is 3-12 months, and the ...
View Page

16.  Study Posting (4519) Trial #98941, Anemia, Tianjin, China
...leukemia who are receiving anti-tumor chemotherapy. Patients will receive either NeoRecormon or standard therapy (blood transfusion and iron supplement) The anticipated time on study treatment is 3-12 months, and the ...
View Page

17.  Study Posting (4519) Trial #97120, Anemia, Shanghai, China
...leukemia who are receiving anti-tumor chemotherapy. Patients will receive either NeoRecormon or standard therapy (blood transfusion and iron supplement) The anticipated time on study treatment is 3-12 months, and the ...
View Page

18.  Study Posting (4519) Trial #97090, Anemia, Beijing, China
...leukemia who are receiving anti-tumor chemotherapy. Patients will receive either NeoRecormon or standard therapy (blood transfusion and iron supplement) The anticipated time on study treatment is 3-12 months, and the ...
View Page

19.  Study Posting (4167) Trial #95029, Anemia, Gainesville, FL
...Chemotherapy The study will compare the control of anemia ( no need or less need for blood transfusions) of the two named products Patient Inclusion Criteria Must be receiving a minimum of twelve ...
View Page

20.  Study Posting (77) Trial #160885, Kidney Disease, Great Neck, NY
...been hospitalized for more than 2 days in the last 2 months • Have had a blood transfusion within the last 2 months • Are scheduled for a kidney transplant • Have cancer Susan Mathew ...
View Page